164 related articles for article (PubMed ID: 12950155)
21. Increased activity of activator protein-1 transcription factor components ATF2, c-Jun, and c-Fos in human and mouse autosomal dominant polycystic kidney disease.
Le NH; van der Wal A; van der Bent P; Lantinga-van Leeuwen IS; Breuning MH; van Dam H; de Heer E; Peters DJ
J Am Soc Nephrol; 2005 Sep; 16(9):2724-31. PubMed ID: 16049073
[TBL] [Abstract][Full Text] [Related]
22. Gas-forming infection in a renal cyst of a patient with autosomal dominant polycystic kidney disease.
Erkoc R; Sayarlioglu H; Ceylan K; Dogan E; Kara PS
Nephrol Dial Transplant; 2006 Feb; 21(2):555-6. PubMed ID: 16249206
[No Abstract] [Full Text] [Related]
23. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.
Xu N; Glockner JF; Rossetti S; Babovich-Vuksanovic D; Harris PC; Torres VE
J Nephrol; 2006; 19(4):529-34. PubMed ID: 17048214
[TBL] [Abstract][Full Text] [Related]
24. Autosomal dominant polycystic kidney disease-associated glomerulonephritides.
Ben Hmida M; Hachicha J; Jarraya F; Kharrat M; Jlidi R; Jarraya A
Transplant Proc; 1995 Oct; 27(5):2718-9. PubMed ID: 7482888
[No Abstract] [Full Text] [Related]
25. Tuberous sclerosis complex with polycystic kidney disease of the adult type: the TSC2/ADPKD1 contiguous gene syndrome.
Bisceglia M; Galliani C; Carosi I; Simeone A; Ben-Dor D
Int J Surg Pathol; 2008 Oct; 16(4):375-85. PubMed ID: 18611938
[TBL] [Abstract][Full Text] [Related]
26. RLS3: fine-mapping of an autosomal dominant locus in a family with intrafamilial heterogeneity.
Liebetanz KM; Winkelmann J; Trenkwalder C; Pütz B; Dichgans M; Gasser T; Müller-Myhsok B
Neurology; 2006 Jul; 67(2):320-1. PubMed ID: 16864828
[TBL] [Abstract][Full Text] [Related]
27. PKDB: Polycystic Kidney Disease Mutation Database--a gene variant database for autosomal dominant polycystic kidney disease.
Gout AM; Martin NC; Brown AF; Ravine D
Hum Mutat; 2007 Jul; 28(7):654-9. PubMed ID: 17370309
[TBL] [Abstract][Full Text] [Related]
28. Medullary cystic kidney disease type 1 in a large Native-American kindred.
Kiser RL; Wolf MT; Martin JL; Zalewski I; Attanasio M; Hildebrandt F; Klemmer P
Am J Kidney Dis; 2004 Oct; 44(4):611-7. PubMed ID: 15384011
[TBL] [Abstract][Full Text] [Related]
29. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
[TBL] [Abstract][Full Text] [Related]
30. [Autosomal dominant polycystic kidney disease in infancy].
Kuwertz-Bröking E; Rabe H; Grande B; Bulla M
Klin Padiatr; 1991; 203(5):381-3. PubMed ID: 1942947
[TBL] [Abstract][Full Text] [Related]
31. Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen?
Perrone RD; Miskulin DC
Am J Kidney Dis; 2005 Sep; 46(3):557-9. PubMed ID: 16129219
[No Abstract] [Full Text] [Related]
32. [Renal transplantation in patients with autosomal dominant polycystic kidney disease: pre-transplantation evaluation and follow-up].
Bretagnol A; Büchler M; Boutin JM; Nivet H; Lebranchu Y; Chauveau D
Nephrol Ther; 2007 Dec; 3(7):449-55. PubMed ID: 18047999
[TBL] [Abstract][Full Text] [Related]
33. [Autosomal dominant polycystic kidney disease. Proposal to guidelines for patients and their relatives].
Ugeskr Laeger; 2004 Oct; 166(43):3807-11. PubMed ID: 15544110
[No Abstract] [Full Text] [Related]
34. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
[TBL] [Abstract][Full Text] [Related]
35. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Ecder T; Schrier RW
Expert Rev Cardiovasc Ther; 2004 May; 2(3):369-74. PubMed ID: 15151483
[TBL] [Abstract][Full Text] [Related]
36. Intraductal papillary-mucinous neoplasm of the pancreas associated with polycystic liver and kidney disease.
Sato Y; Mukai M; Sasaki M; Kitao A; Yoneda N; Kobayashi D; Imamura Y; Nakanuma Y
Pathol Int; 2009 Mar; 59(3):201-4. PubMed ID: 19261101
[TBL] [Abstract][Full Text] [Related]
37. Common polymorphisms in D12S1034 flanking genes RASSF8 and BHLHB3 are not associated with lung adenocarcinoma risk.
Falvella FS; Spinola M; Manenti G; Conti B; Pastorino U; Skaug V; Haugen A; Dragani TA
Lung Cancer; 2007 Apr; 56(1):1-7. PubMed ID: 17194498
[TBL] [Abstract][Full Text] [Related]
38. Selective, concurrent bilateral nephrectomies at renal transplantation for autosomal dominant polycystic kidney disease.
Wagner MD; Prather JC; Barry JM
J Urol; 2007 Jun; 177(6):2250-4; discussion 2254. PubMed ID: 17509331
[TBL] [Abstract][Full Text] [Related]
39. Mutations in SEC63 cause autosomal dominant polycystic liver disease.
Davila S; Furu L; Gharavi AG; Tian X; Onoe T; Qian Q; Li A; Cai Y; Kamath PS; King BF; Azurmendi PJ; Tahvanainen P; Kääriäinen H; Höckerstedt K; Devuyst O; Pirson Y; Martin RS; Lifton RP; Tahvanainen E; Torres VE; Somlo S
Nat Genet; 2004 Jun; 36(6):575-7. PubMed ID: 15133510
[TBL] [Abstract][Full Text] [Related]
40. Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1.
Tazón-Vega B; Vilardell M; Pérez-Oller L; Ars E; Ruiz P; Devuyst O; Lens X; Fernández-Llama P; Ballarín J; Torra R
Nephrol Dial Transplant; 2007 Jun; 22(6):1567-77. PubMed ID: 17303584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
